Adipose-Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting. [PDF]
Shimada T +18 more
europepmc +1 more source
Reframing cancer cachexia: the vagal brain-liver axis as a novel neuro-metabolic target. [PDF]
Wei D, Lin X, Bresalier RS.
europepmc +1 more source
Impact of the Timing of Initial Anamorelin Administration in Advanced Gastrointestinal Cancer With Cancer Cachexia. [PDF]
Yoshida D +9 more
europepmc +1 more source
Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database. [PDF]
Morimoto K +12 more
europepmc +1 more source
Temporal Trends in Mortality Related to Pancreatic Cancer and Cachexia in the United States. [PDF]
Pakkirisamy Kannan S +5 more
europepmc +1 more source
Ponsegromab: The new miracle drug for cancer cachexia.
Paikray E, Rout A, Tripathy R.
europepmc +1 more source
Related searches:
Cancer-associated cachexia is a disorder characterized by loss of body weight with specific losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination of reduced food intake and metabolic changes, including elevated energy expenditure, excess catabolism and inflammation.
Vickie E Baracos +2 more
exaly +6 more sources
Definition and classification of cancer cachexia: an international consensus
Lancet Oncology, The, 2011Ingvar Bosaeus +2 more
exaly +2 more sources
Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
Nature Medicine, 2020Rowena Suriben +2 more
exaly +2 more sources

